fbpx Warning:
OSSIX® Plus must not be used in patients with known collagen hypersensitivity, sensitivity to porcine-derived materials, or suffer from autoimmune diseases and connective tissue diseases. As the membrane is of a collagen origin, allergic reactions may not be entirely excluded. Please read IFU before use and for additional information on indications, contraindications, warnings and precautions.
text text

OSSIX® Plus

Ossifying Collagen Barrier Membrane
Powered by GLYMATRIX® Technology1
for Guided Bone (GBR) and Tissue (GTR) Regeneration

Why Choose OSSIX® Plus?

  • Extended Barrier Functionality: Provides up to 6 months of barrier function, ensuring optimal protection during the critical healing period2,3-6
  • Degradation Resistance: Has long-lasting resistance to degradation. When exposed, it remains resistant for 3-5 weeks7
  • Exceptional Handling: conforms easily to the shape of the alveolar ridge8-9
  • Resorbable and Biocompatible: Integrates with surrounding tissues3-7, eliminating the need for site re-entry for removal3-7
  • Proven Efficacy: Powered by GLYMATRIX® Technology,1 backed by clinical studies and real-world applications1-9

Applications of OSSIX® Plus

OSSIX® Plus is versatile and can be used in a wide range of clinical procedures, including:

  • Alveolar ridge preservation consequent to tooth (teeth) extraction(s)
  • Over the window in lateral window sinus elevation procedures
  • Ridge augmentation around implants inserted
  • In implants with vertical bone loss due to infection, only in cases where satisfactory debridement and implant surface disinfection can be achieved
  • For treatment of recession defects, together with coronally positioned flap
  • Simultaneous ridge augmentation and implant insertions

*For detailed guidance on indications and contraindications, refer to the Instructions for Use (IFU) available in our IFU Library.

Sizing Options:

OSSIX® Plus is available in three convenient sizes to fit your clinical needs:

15×25 mm 25×30 mm 30×40 mm

*Images shown are not to scale.

References1. Data on file (GLYMATRIX® based products legacy doc)
2. Zubery Y Goldlust, A. Alves, A Nir E (2007) Ossification of a novel cross-linked porcine collagen barrier in guided bone regeneration in dogs. JPeriodontol 78:112-121.
3. Zubery Y, Nir E, and Goldlust A. (2008). Ossification of a Collagen Membrane Cross-Linked by Sugar: A Human Case Series. Journal of Periodontology, 79(6), 1101–1107
4. Levin, B.P. and Y. Zubery, Use of a Sugar Cross-Linked Collagen Membrane Offers Cell Exclusion and Ossification. Compend Contin Educ Dent (15488578), 2018. 39(1): p. 44-48
5. Tal H, Kozlovsky A, Artzi Z, Nemcovsky CE, Moses O. Long-term Bio-degradation of Cross-Linked and Non-Cross-Linked Collagen Barriers in Human Guided Bone Regeneration. Clin Oral Implants Res. 2008 Mar;19(3):295-302. doi: 10.1111/j.1600-0501. 2007. 01424.x. Epub 2008 Jan 7.
6. Klinger A, Asad R, Shapira L, Zubery Y. (2010) In vivo Degradation of Collagen Barrier Membranes Exposed to the Oral Cavity. Clin. Oral Impl. Res. 21, 873–876
7. Hong HR, Chen C-Y, Kim DM, and Machtei EE. (2018). Ridge preservation procedures revisited: a randomized controlled trial to evaluate dimensional changes with two different surgical protocols. Journal of Periodontology
8. Data on file (Wet Adherence Property of OSSIX® Plus and OSSIX® Volumax Design Requirement)
9. Data on file (User Feedback Survey report 2024. Out of 33 respondents, 55% stated that it is very easy to use, while 36% said it is easy to use)

Expand Your Knowledge: Visit Our Clinical Library

 

Elevate Your Dental Practice with OSSIX® Plus Ossifying Collagen Membrane

Discover how OSSIX® Plus can transform your regenerative treatments.

Find a Dealer Near Me

*OSSIX® products are available in more than 55 countries.
Please contact your local distributor/sales representative for more details regarding availability in your region.

WarningWarning:
OSSIX® Plus must not be used in patients with known collagen hypersensitivity, sensitivity to porcine-derived materials, or suffer from autoimmune diseases and connective tissue diseases. As the membrane is of a collagen origin, allergic reactions may not be entirely excluded. Please read IFU before use and for additional information on indications, contraindications, warnings and precautions.

Contact Us

Please complete this form and a Datum Dental representative will contact you

    What are you interested in? Please select
    • What are you interested in? Please select
    • Sales - Want to buy OSSIX products
    • Sales - Need additional information
    • Support - Need support for my product
    • Partner - Looking to collaborate with Datum Dental
    • Marketing - Request or offer marketing services
    • Other

    —Please choose an option—
    • —Please choose an option—
    • Dentist / Periodontist / Oral Surgeon / maxillofacial Surgeon / other specialty
    • Distributor
    • Investor
    • Other

    —Please choose an option—
    • —Please choose an option—
    • General practitioner
    • Implantologist
    • Maxillofacial surgeon
    • Oral Surgeon
    • Periodontist
    • Prosthodontist
    • Stomatologist

    Select Country
    • Select Country
    • Afghanistan
    • Albania
    • Algeria
    • American Samoa
    • Andorra
    • Angola
    • Anguilla
    • Antigua and Barbuda
    • Argentina
    • Armenia
    • Armenia
    • Aruba
    • Australia
    • Austria
    • Azerbaijan
    • Azerbaijan
    • Bahamas
    • Bahrain
    • Bangladesh
    • Barbados
    • Belarus
    • Belgium
    • Belize
    • Benin
    • Bermuda
    • Bhutan
    • Bolivia
    • Bonaire
    • Bosnia and Herzegovina
    • Botswana
    • Bouvet Island (Bouvetoya)
    • Brazil
    • British Indian Ocean Territory (Chagos Archipelago)
    • British Virgin Islands
    • Brunei Darussalam
    • Bulgaria
    • Burkina Faso
    • Burundi
    • Cambodia
    • Cameroon
    • Canada
    • Cape Verde
    • Cayman Islands
    • Central African Republic
    • Chad
    • Chile
    • China
    • Christmas Island
    • Cocos (Keeling) Islands
    • Colombia
    • Comoros
    • Congo
    • Congo
    • Cook Islands
    • Costa Rica
    • Cote d'Ivoire
    • Croatia
    • Cuba
    • Curaçao
    • Cyprus
    • Cyprus
    • Czech Republic
    • Denmark
    • Djibouti
    • Dominica
    • Dominican Republic
    • Ecuador
    • Egypt
    • El Salvador
    • Equatorial Guinea
    • Eritrea
    • Estonia
    • Ethiopia
    • Falkland Islands (Malvinas)
    • Faroe Islands
    • Fiji
    • Finland
    • France
    • French Guiana
    • French Polynesia
    • French Southern Territories
    • Gabon
    • Gambia
    • Georgia
    • Georgia
    • Germany
    • Ghana
    • Gibraltar
    • Greece
    • Greenland
    • Grenada
    • Guadeloupe
    • Guam
    • Guatemala
    • Guernsey
    • Guinea
    • Guinea-Bissau
    • Guyana
    • Haiti
    • Heard Island and McDonald Islands
    • Holy See (Vatican City State)
    • Honduras
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Iran
    • Iraq
    • Ireland
    • Isle of Man
    • Israel
    • Italy
    • Jamaica
    • Japan
    • Jersey
    • Jordan
    • Kazakhstan
    • Kazakhstan
    • Kenya
    • Kiribati
    • Korea
    • Korea
    • Kuwait
    • Kyrgyz Republic
    • Lao People's Democratic Republic
    • Latvia
    • Lebanon
    • Lesotho
    • Liberia
    • Libyan Arab Jamahiriya
    • Liechtenstein
    • Lithuania
    • Luxembourg
    • Macao
    • Macedonia
    • Madagascar
    • Malawi
    • Malaysia
    • Maldives
    • Mali
    • Malta
    • Marshall Islands
    • Martinique
    • Mauritania
    • Mauritius
    • Mayotte
    • Mexico
    • Micronesia
    • Moldova
    • Monaco
    • Mongolia
    • Montenegro
    • Montserrat
    • Morocco
    • Mozambique
    • Myanmar
    • Namibia
    • Nauru
    • Nepal
    • Netherlands
    • Netherlands Antilles
    • New Caledonia
    • New Zealand
    • Nicaragua
    • Niger
    • Nigeria
    • Niue
    • Norfolk Island
    • Northern Mariana Islands
    • Norway
    • Oman
    • Pakistan
    • Palau
    • Palestinian Territory
    • Panama
    • Papua New Guinea
    • Paraguay
    • Peru
    • Philippines
    • Pitcairn Islands
    • Poland
    • Portugal
    • Puerto Rico
    • Qatar
    • Reunion
    • Romania
    • Russian Federation
    • Rwanda
    • Saint Barthelemy
    • Saint Helena
    • Saint Kitts and Nevis
    • Saint Lucia
    • Saint Martin
    • Saint Pierre and Miquelon
    • Saint Vincent and the Grenadines
    • Samoa
    • San Marino
    • Sao Tome and Principe
    • Saudi Arabia
    • Senegal
    • Serbia
    • Seychelles
    • Sierra Leone
    • Singapore
    • Sint Maarten (Netherlands)
    • Slovakia (Slovak Republic)
    • Slovenia
    • Solomon Islands
    • Somalia
    • South Africa
    • South Georgia & S. Sandwich Islands
    • Spain
    • Sri Lanka
    • Sudan
    • Suriname
    • Svalbard & Jan Mayen Islands
    • Swaziland
    • Sweden
    • Switzerland
    • Syrian Arab Republic
    • Taiwan
    • Tajikistan
    • Tanzania
    • Thailand
    • Timor-Leste
    • Togo
    • Tokelau
    • Tonga
    • Trinidad and Tobago
    • Tunisia
    • Turkey
    • Turkey
    • Turkmenistan
    • Turks and Caicos Islands
    • Tuvalu
    • U.S. Minor Outlying Islands
    • U.S. Virgin Islands
    • Uganda
    • Ukraine
    • United Arab Emirates
    • United Kingdom
    • United States
    • Uruguay
    • Uzbekistan
    • Vanuatu
    • Venezuela
    • Vietnam
    • Wallis and Futuna
    • Western Sahara
    • Yemen
    • Zambia
    • Zimbabwe

    [recaptcha]





    Lets Talk